Ocular Therapeutix (OCUL) CSO Sanjay Nayak Sells 1,897 Shares

What Happened
Sanjay Nayak, Chief Strategy Officer of Ocular Therapeutix (OCUL), sold 1,897 shares on 2026-08-24 at a weighted average price of $10.78, generating proceeds of $20,450. The sale was a sell-to-cover to satisfy tax withholding associated with restricted stock units that vested on August 22, 2026, and was executed under a durable automatic sale instruction adopted February 21, 2024 — not a discretionary trade.

Key Details

• Transaction date: 2026-08-24; Form 4 filed 2026-08-26 (timely filing).
• Transaction type/code: Sale (S); purpose: tax withholding (sell-to-cover, footnote F1).
• Shares sold: 1,897; weighted average price reported: $10.78; price range across multiple executions: $10.6425–$10.8990 (footnote F2).
• Proceeds: $20,450.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 confirms the sale was automatic to cover tax withholding on RSU vesting; F2 notes multiple executions and offers to provide per-price breakdown on request.

Context
Sell-to-cover transactions to satisfy tax withholding on vested RSUs are routine and typically do not signal a change in an insider’s view of the company. This sale was executed automatically under a pre-established instruction and therefore should be interpreted as administrative rather than a discretionary insider sale.